|
|
|
Insider
Information: |
Bedrosian Camille L |
Relationship: |
|
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
211,363 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$3,055,330 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
211,363 |
|
|
Total
Value |
$3,055,330 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-14.4%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ultragenyx Pharmaceutical Inc |
RARE |
EVP and Chief Medical ... |
2023-03-01 |
46,720 |
2018-01-30 |
0 |
Premium* |
|
Crinetics Pharmaceuticals, Inc. |
CRNX |
|
2024-06-07 |
9,400 |
2023-06-16 |
0 |
Premium* |
|
Amylyx Pharmaceuticals, Inc. |
AMLX |
|
2024-04-16 |
155,243 |
2023-11-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
32 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Medical Officer |
|
2020-05-06 |
4 |
D |
$66.26 |
$16,499 |
D/D |
(249) |
36,051 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Medical Officer |
|
2020-10-14 |
4 |
S |
$88.00 |
$23,056 |
D/D |
(262) |
35,789 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Medical Officer |
|
2021-10-14 |
4 |
S |
$81.14 |
$29,129 |
D/D |
(359) |
38,416 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Medical Officer |
|
2021-05-06 |
4 |
S |
$113.67 |
$41,376 |
D/D |
(364) |
38,775 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Medical Officer |
|
2020-03-01 |
4 |
D |
$56.08 |
$70,044 |
D/D |
(1,249) |
36,300 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Medical Officer |
|
2019-10-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,437 |
26,239 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Medical Officer |
|
2019-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,438 |
24,802 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Medical Officer |
|
2020-01-30 |
4 |
D |
$53.23 |
$86,446 |
D/D |
(1,624) |
24,615 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Medical Officer |
|
2019-01-30 |
4 |
D |
$48.85 |
$79,919 |
D/D |
(1,636) |
16,364 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Medical Officer |
|
2022-01-30 |
4 |
S |
$66.30 |
$109,859 |
D/D |
(1,657) |
36,759 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Medical Officer |
|
2021-01-30 |
4 |
S |
$140.36 |
$314,827 |
D/D |
(2,243) |
33,546 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Medical Officer |
|
2021-09-01 |
4 |
AS |
$100.03 |
$250,075 |
D/D |
(2,500) |
38,775 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Medical Officer |
|
2021-09-01 |
4 |
OE |
$55.00 |
$137,500 |
D/D |
2,500 |
41,275 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Medical Officer |
|
2021-09-02 |
4 |
OE |
$55.00 |
$137,500 |
D/D |
2,500 |
41,275 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Medical Officer |
|
2021-09-02 |
4 |
AS |
$100.18 |
$250,450 |
D/D |
(2,500) |
38,775 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Medical Officer |
|
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,663 |
50,601 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Medical Officer |
|
2022-03-01 |
4 |
S |
$66.62 |
$187,935 |
D/D |
(2,821) |
33,938 |
0 |
- |
|
CRNX |
Crinetics Pharmaceuticals... |
|
|
2024-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,400 |
9,400 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Medical Officer |
|
2023-03-01 |
4 |
S |
$45.25 |
$175,615 |
D/D |
(3,881) |
46,720 |
0 |
% |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Medical Officer |
|
2021-03-01 |
4 |
S |
$138.18 |
$627,752 |
D/D |
(4,543) |
39,139 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Medical Officer |
|
2021-04-15 |
4 |
AS |
$109.09 |
$545,450 |
D/D |
(5,000) |
39,139 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Medical Officer |
|
2021-04-15 |
4 |
OE |
$55.00 |
$275,000 |
D/D |
5,000 |
44,139 |
0 |
- |
|
CRNX |
Crinetics Pharmaceuticals... |
Director |
|
2023-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
6,000 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Medical Officer |
|
2019-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,000 |
23,364 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Medical Officer |
|
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,136 |
43,682 |
0 |
- |
|
32 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|